Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1002/uog.7338.
Collaborators, Affiliations
- PMID: 19918965
- DOI: 10.1002/uog.7338
Free article
Randomized Controlled Trial
Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial
J M O'Brien et al. Ultrasound Obstet Gynecol. 2009 Dec.
Free article
Abstract
Objectives: To determine whether progesterone supplementation alters cervical shortening in women at increased risk for preterm birth.
Methods: We performed a planned secondary analysis from a large, multinational preterm birth prevention trial of daily intravaginal progesterone gel, 90 mg, compared with placebo in women with a history of spontaneous preterm birth or premature cervical shortening. Transvaginal cervical length measurements were obtained in all randomized patients at baseline (18 + 0 to 22 + 6 weeks' gestation) and at 28 weeks' gestation. For this secondary analysis, the difference in cervical length between these time points was compared for the study population with a history of spontaneous preterm birth and for a population with premature cervical shortening (< or = 30 mm) at randomization. Differences between groups in cervical length for the 28-week examination were analyzed using ANCOVA, including adjustment for relevant clinical parameters and maternal characteristics.
Results: Data were analyzed from 547 randomized patients with a history of preterm birth. The progesterone-treated patients had significantly less cervical shortening than the placebo group (difference 1.6 (95% CI, 0.3-3.0) mm; P = 0.02, ANCOVA). In the population of 104 subjects with premature cervical shortening at randomization, the cervical length also differed significantly on multivariable analysis, with the treatment group preserving more cervical length than the placebo group (difference 3.3 (95% CI, 0.3-6.2) mm; P = 0.03, ANCOVA), with adjustment for differences in cervical length at screening. A significant difference was also observed between groups for categorical outcomes including the frequency of cervical length progression to < or = 25 mm and a > or = 50% reduction in cervical length from baseline in this subpopulation.
Conclusions: Intravaginal progesterone enhances preservation of cervical length in women at high risk for preterm birth.
Trial registration: ClinicalTrials.gov NCT00086177.
Copyright 2009 ISUOG. Published by John Wiley & Sons, Ltd.
Similar articles
- Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. O'Brien JM, et al. Ultrasound Obstet Gynecol. 2007 Oct;30(5):687-96. doi: 10.1002/uog.5158. Ultrasound Obstet Gynecol. 2007. PMID: 17899572 Clinical Trial. - Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. DeFranco EA, et al. Ultrasound Obstet Gynecol. 2007 Oct;30(5):697-705. doi: 10.1002/uog.5159. Ultrasound Obstet Gynecol. 2007. PMID: 17899571 Clinical Trial. - Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
Rehal A, Benkő Z, De Paco Matallana C, Syngelaki A, Janga D, Cicero S, Akolekar R, Singh M, Chaveeva P, Burgos J, Molina FS, Savvidou M, De La Calle M, Persico N, Quezada Rojas MS, Sau A, Greco E, O'Gorman N, Plasencia W, Pereira S, Jani JC, Valino N, Del Mar Gil M, Maclagan K, Wright A, Wright D, Nicolaides KH. Rehal A, et al. Am J Obstet Gynecol. 2021 Jan;224(1):86.e1-86.e19. doi: 10.1016/j.ajog.2020.06.050. Epub 2020 Jun 26. Am J Obstet Gynecol. 2021. PMID: 32598909 Clinical Trial. - Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
Romero R, Conde-Agudelo A, El-Refaie W, Rode L, Brizot ML, Cetingoz E, Serra V, Da Fonseca E, Abdelhafez MS, Tabor A, Perales A, Hassan SS, Nicolaides KH. Romero R, et al. Ultrasound Obstet Gynecol. 2017 Mar;49(3):303-314. doi: 10.1002/uog.17397. Ultrasound Obstet Gynecol. 2017. PMID: 28067007 Free PMC article. Review. - Novel developments on cervical length screening and progesterone for preventing preterm birth.
Berghella V. Berghella V. BJOG. 2009 Jan;116(2):182-7. doi: 10.1111/j.1471-0528.2008.02008.x. BJOG. 2009. PMID: 19076950 Review.
Cited by
- Predictive accuracy of changes in transvaginal sonographic cervical length over time for preterm birth: a systematic review and metaanalysis.
Conde-Agudelo A, Romero R. Conde-Agudelo A, et al. Am J Obstet Gynecol. 2015 Dec;213(6):789-801. doi: 10.1016/j.ajog.2015.06.015. Epub 2015 Jun 10. Am J Obstet Gynecol. 2015. PMID: 26070703 Free PMC article. Review. - Agonist-Dependent Downregulation of Progesterone Receptors in Human Cervical Stromal Fibroblasts.
Ackerman WE 4th, Summerfield TL, Mesiano S, Schatz F, Lockwood CJ, Kniss DA. Ackerman WE 4th, et al. Reprod Sci. 2016 Jan;23(1):112-23. doi: 10.1177/1933719115597787. Epub 2015 Aug 4. Reprod Sci. 2016. PMID: 26243545 Free PMC article. - Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle.
Kuon RJ, Shi SQ, Maul H, Sohn C, Balducci J, Maner WL, Garfield RE. Kuon RJ, et al. Am J Obstet Gynecol. 2010 May;202(5):455.e1-9. doi: 10.1016/j.ajog.2010.03.025. Am J Obstet Gynecol. 2010. PMID: 20452487 Free PMC article. - A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor.
Kuon RJ, Shi SQ, Maul H, Sohn C, Balducci J, Shi L, Garfield RE. Kuon RJ, et al. Am J Obstet Gynecol. 2011 Jul;205(1):82.e15-20. doi: 10.1016/j.ajog.2011.02.048. Epub 2011 Feb 23. Am J Obstet Gynecol. 2011. PMID: 21497789 Free PMC article. - Maternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate.
Egerman R, Ramsey R, Istwan N, Rhea D, Stanziano G. Egerman R, et al. J Obes. 2014;2014:563243. doi: 10.1155/2014/563243. Epub 2014 Oct 27. J Obes. 2014. PMID: 25405027 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources